CN106309151A - Protein vitamin pink mask liquid and production method - Google Patents
Protein vitamin pink mask liquid and production method Download PDFInfo
- Publication number
- CN106309151A CN106309151A CN201610688008.0A CN201610688008A CN106309151A CN 106309151 A CN106309151 A CN 106309151A CN 201610688008 A CN201610688008 A CN 201610688008A CN 106309151 A CN106309151 A CN 106309151A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- content
- albumen
- pink
- mask liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 37
- 229930003231 vitamin Natural products 0.000 title claims abstract description 24
- 235000013343 vitamin Nutrition 0.000 title claims abstract description 24
- 239000011782 vitamin Substances 0.000 title claims abstract description 24
- 229940088594 vitamin Drugs 0.000 title claims abstract description 24
- 150000003722 vitamin derivatives Chemical class 0.000 title claims abstract description 24
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 10
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 9
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 8
- 102000008186 Collagen Human genes 0.000 claims abstract description 19
- 108010035532 Collagen Proteins 0.000 claims abstract description 19
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims abstract description 18
- 229930003779 Vitamin B12 Natural products 0.000 claims abstract description 15
- 235000019163 vitamin B12 Nutrition 0.000 claims abstract description 15
- 239000011715 vitamin B12 Substances 0.000 claims abstract description 15
- 239000013543 active substance Substances 0.000 claims abstract description 11
- 235000016709 nutrition Nutrition 0.000 claims abstract description 9
- 239000003855 balanced salt solution Substances 0.000 claims abstract description 8
- 229920001436 collagen Polymers 0.000 claims abstract description 6
- 230000001815 facial effect Effects 0.000 claims description 41
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 36
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 26
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 claims description 24
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 20
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 20
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 14
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims description 12
- 229940054269 sodium pyruvate Drugs 0.000 claims description 12
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 10
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 10
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 10
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 10
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims description 10
- 235000019799 monosodium phosphate Nutrition 0.000 claims description 10
- 239000011780 sodium chloride Substances 0.000 claims description 10
- 235000002639 sodium chloride Nutrition 0.000 claims description 10
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 10
- 239000008103 glucose Substances 0.000 claims description 9
- 239000001103 potassium chloride Substances 0.000 claims description 9
- 235000011164 potassium chloride Nutrition 0.000 claims description 9
- 238000002372 labelling Methods 0.000 claims description 7
- 230000006798 recombination Effects 0.000 claims description 7
- 238000005215 recombination Methods 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 229960005150 glycerol Drugs 0.000 claims description 2
- 238000005374 membrane filtration Methods 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 230000008595 infiltration Effects 0.000 claims 1
- 238000001764 infiltration Methods 0.000 claims 1
- 239000011591 potassium Substances 0.000 claims 1
- 229910052700 potassium Inorganic materials 0.000 claims 1
- 235000007686 potassium Nutrition 0.000 claims 1
- 210000003491 skin Anatomy 0.000 abstract description 31
- 239000002537 cosmetic Substances 0.000 abstract description 10
- 150000002500 ions Chemical class 0.000 abstract description 3
- 230000003020 moisturizing effect Effects 0.000 abstract description 3
- 230000037394 skin elasticity Effects 0.000 abstract description 3
- 230000002087 whitening effect Effects 0.000 abstract description 3
- 230000007774 longterm Effects 0.000 abstract description 2
- 210000004927 skin cell Anatomy 0.000 abstract description 2
- 235000012041 food component Nutrition 0.000 abstract 3
- 206010014970 Ephelides Diseases 0.000 abstract 1
- 208000003351 Melanosis Diseases 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- -1 2-carbonyl propionic acid sodium Chemical compound 0.000 description 7
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 7
- 229960005323 phenoxyethanol Drugs 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 6
- 241000255789 Bombyx mori Species 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 210000000589 cicatrix Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000588722 Escherichia Species 0.000 description 2
- 108010022355 Fibroins Proteins 0.000 description 2
- 101500025419 Homo sapiens Epidermal growth factor Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229940116978 human epidermal growth factor Drugs 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- GVUGOAYIVIDWIO-UFWWTJHBSA-N nepidermin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C1=CC=C(O)C=C1 GVUGOAYIVIDWIO-UFWWTJHBSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000009965 odorless effect Effects 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010003399 Arthropod bite Diseases 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 241000561734 Celosia cristata Species 0.000 description 1
- 241000050051 Chelone glabra Species 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010040849 Skin fissures Diseases 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 210000001520 comb Anatomy 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 229940076788 pyruvate Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000037204 skin physiology Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0212—Face masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/23—Sulfur; Selenium; Tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Zoology (AREA)
- Cosmetics (AREA)
Abstract
The invention belongs to the technical field of cosmetics, and particularly relates to protein vitamin pink mask liquid and a production method thereof. The mask liquid comprises active substances and a nutritional component, wherein the active substances are recombinant human collagen and oligopeptide-1 protein; the nutritional component is vitamin B12; the content of the recombinant human collagen is 0.0002-0.001%; the content of the oligopeptide-1 protein is 0.0002-0.001%; the content of the vitamin B12 is 0.0005-0.005%; the active substances and the nutritional component are dissolved in a balanced salt solution. The protein vitamin pink mask liquid contains a variety of nutritional ions, provides a good growing environment for skin cells, can make rough skin white, compact, tender and smooth after long-term use, and has efficacy of rapidly repairing damaged skin, moisturizing the skin, enhancing skin elasticity, compacting the skin, whitening the skin and removing freckles.
Description
Technical field
The invention belongs to cosmetic technical field, specially the pink facial mask liquid of albumen vitamin and production method thereof.
Background technology
Facial film is the most common a kind of skin care item.Mainly by acting the of short duration time covered at face, outside being temporarily isolating
Boundary's environment, makes skin temperature raise, and skin pore is expanded, and accelerates sweat gland secretion and blood circulation, makes in skin oxygen content
Rise, accelerate to get rid of oil substances in the metabolic product of skin epidermis and skin.Meanwhile, the moisture in facial film, nutrition become
Divide, active component penetrates into epidermis cell, makes skin become soft, and it is flexible that skin is rich in gloss.
Facial film mainly has mud cream type, tear-pull, gel-type, four kinds of l Water Paper type at present.
Summary of the invention
It is an object of the invention to provide albumen vitamin pink mask product formula and production technology thereof.This product with
Recombination human source collagen protein and oligopeptide-1 albumen are main active substances, with vitamin B12 as nutritional labeling.
The present invention adopts the following technical scheme that realization:
A kind of pink facial mask liquid of albumen vitamin, including active substance and nutritional labeling, described active substance is recombination human source glue
Former albumen and oligopeptide-1 albumen, described nutritional labeling is vitamin B12.
The recombination human source collagen protein of active component, for type III human collagen, sequence is the sequence of long-term screening and optimizing
Row, use escherichia expression system, and the sequence in gene has carried out codon optimized expression for escherichia expression system
Form, its preparation method as 201210482543.2(recombination human source collagen protein and production method thereof) described in.This is heavy
Group people's derived collagen albumen has extraordinary hydrophilic and stability, its aminoacid composition and natural collagen protein aminoacid sequence
Appropriate section 100% is identical, is applied to human body and will not produce immunologic rejection and anaphylaxis, can be widely applied to biological medicine
And cosmetic industry, the function of native protein can be exercised in human body.
Oligopeptide-1 of active component, i.e. EGF(recombinant human epidermal growth factor).EGF can promote the proliferation and differentiation of cell,
Thus replace senile cell and the process of dead cell with regenerative cell.What Traditional makeup rose is outside modification, it is impossible to
Fundamentally solve skin problem, and EGF applies the physiological structure being based on human body skin in cosmetics, at molecular water
On Ping, cell repaired and adjust, having and quickly repair damaged skin, improving the reparation of skin, nursing；Skin care, increases
Strong skin elasticity, calms down eye wrinkle-removing, firm skin；Whitening and speckle dispelling, sun-proof and after-sun；And there is anti-acne, go scar
Trace, shortening wound healing time and the effect of minimizing cicatrization, be described as " the beautiful factor " by beauty treatment circle.This oligopeptide-1 preparation side
Method is shown in the method that 200810211603.0(prepares dissolvable high activity recombinant human epidermal growth factor) record, repeat no more.
Vitamin B12 is again cobalamine (cobalamin), is the vitamin uniquely containing metallic element, ties for light red needle-like
Crystalline substance, soluble in water and ethanol, the most stable under pH value 4.5～5.0 mild acid conditions, strong acid (pH < 2) or alkaline solution decompose,
Heat can have to a certain degree to be destroyed, but the high-temperature sterilization of short time loss is little, meets high light or ultraviolet is easily destroyed.In skin protection
Cosmetic can be obviously improved skin is tired out, obscure, dry skin；Substantially desalinate the microgroove produced because of the age and wrinkle；Maintenance day
Shine, the autumn and winter are dried etc. that the skin caused is red and swollen, decortication, pain；Repair pox cicatrix mark, the cicatrix of mosquito bite, empyrosis and
The cicatrix that plastic operation stays.
Facial mask liquid of the present invention is with recombination human source collagen protein and oligopeptide-1 albumen as main active substances, with vitamin B12
For nutritional labeling.
Preferably, with facial mask liquid weight for counting, the content of described recombination human source collagen protein is 0.0002 ~ 0.001%；Institute
The content stating oligopeptide-1 albumen is 0.0002 ~ 0.001%；The content of described vitamin B12 is 0.0005 ~ 0.005%.
Preferably, described active substance and nutritional labeling are dissolved in balanced salt solution.Balanced salt solution, i.e. main by inorganic
Salt, glucose form, and are the internal salinity of biological maintenance and the liquid of body fluid balance, can maintain cell normal osmosis and replacement, protect
Hold pH stable, provide comfortable production metabolism environment for regenerative cell, and necessary nutrient ions is provided.
Described balanced salt solution includes potassium chloride, magnesium sulfate, sodium chloride, sodium dihydrogen phosphate, L-glutaminate and glucose sugar,
Wherein, in terms of facial mask liquid weight, the content of potassium chloride is 0.02 ~ 0.05%, and the content of magnesium sulfate is 0.01 ~ 0.05%, sodium chloride
Content be 0.5 ~ 0.8%, the content of sodium dihydrogen phosphate is 0.01 ~ 0.03%, and the content of L-glutaminate is 0.05 ~ 0.08%, Portugal
The content of grape sugar is 0.2 ~ 0.5%.
Preferably, described balanced salt solution adds glycerol, γ-aminobutyric acid, Sodium Pyruvate and hyaluronate sodium.
Glycerol is achromaticity and clarification thick liquid, and odorless has warm sweet taste.Be widely used in medicine, food, cosmetics, toothpaste,
Nicotiana tabacum L. etc..Can be as good solvent, wetting agent etc. in cosmetics.
γ-aminobutyric acid (γ-aminobutyric acid (GABA)) is a kind of active skull cap components, widely distributed
In animal and plant body, white plates or acicular crystal；Micro-smelly, there is hygroscopy；It is highly soluble in water, is slightly soluble in hot ethanol, insoluble
In cold ethanol, ether and benzene.Being inhibitory neurotransmitter critically important in central nervous system, it participates in multiple metabolic activity,
There is the highest physiologically active.Up-to-date research shows, GABA has and prevents skin aging, eliminates body odor, improves lipid metabolism,
Prevent the functions such as arteriosclerosis high-efficient fat reducing.
Sodium Pyruvate is modal pyruvate, calls pyruvic sodium, 2-carbonyl propionic acid sodium, white crystalline powder；
Soluble in water, atomic it is dissolved in alcohol.Being a class endogenous small-molecule substance, Sodium Pyruvate and acetone acid are all naturally present in human body
In, and participate in whole body and respectively organize the metabolism with organ, it is required material in cellular metabolism.
Hyaluronate sodium (Sodium Hyaluronate): for the material extracted from cockscomb, it is possible to pass through Lactococcus
Fermentation prepares, and for white or off-white color granule or powder, odorless, has the strongest hygroscopicity, is dissolved in water, insoluble in alcohol, ketone, second
The organic solvents such as ether.Its aqueous solution is electronegative, has the highest viscoelasticity, rheological characteristic and osmotic pressure during high concentration.At cosmetics
Field uses more, have moisture-keeping function.In the products such as the cream of cosmetics, frost, honey, milk, facial film, shampoo, have solely
Special keeps skin, the moisture of hair, makes skin moisturizing smooth, and fine and smooth tender, high resilience, hair is rich in gloss；Have simultaneously
Have and prevent chapped skin, wrinkle resistant crease-resistant, aesthetic health care and the effect of recovery skin physiology function.
Preferably, in terms of facial mask liquid weight, the content of described glycerol is 5 ~ 8%, and the content of described γ-aminobutyric acid is
0.0002 ~ 0.001%, the content of described Sodium Pyruvate is 0.01 ~ 0.015%, and the content of described hyaluronate sodium is 0.2 ~ 0.5%.
It addition, facial mask liquid can also be added preservative PE 9010 in right amount.PE 9010 is phenoxyethanol and ethylhexyl
The liquid preservative used for cosmetic that glycerol is compounding, Sensiva SC50 have impact on the surface tension on microbial cell film, thus
Improve the antiseptic power of phenoxyethanol.Antibacterial, yeast and mycete are had the inhibitory action of wide spectrum equilibrium, is a kind of typical
Antibacterial aseptic production, also has certain sterilizing ability simultaneously.PE 9010 is highly stable, not facile hydrolysis.Temperature and pH value are had
There is good toleration.Its favorable solubility, even if the most also can be well dispersed in each system.
Containing multiple nutrients ion in the pink facial mask liquid of albumen vitamin of the present invention, provide good life for skin cell
Long environment, life-time service can make that rough skin is pale to compact, tender smooth, and have and quickly repair damaged skin, moistens skin
Skin, strengthens skin elasticity, firm skin, the effectiveness of whitening and speckle dispelling.
A kind of facial film, including face paper, described face paper infiltrates above-mentioned facial mask liquid.Described face paper is silkworm silk face
Film.
L Water Paper type is exactly the face paper infiltrating facial mask liquid of mmic package, and the face paper of this product is a kind of by silkworm silk system
Become, therefore belong to l Water Paper profile film.Silk mask, is mainly made up of silk fiber and activity fibroin.Due to fibroin
In containing 18 kinds of aminoacid of nutritive value great to human body, and be the splendid porous material of good permeability, water absorption,
And non-stimulated to skin, there is " artificial skin " laudatory title.Silk mask has the strongest adsorptivity, can carry attached more facial film elite
Liquid, applies face more comfortable, more firmly, does not haves and fall down and facial mask liquid drip phenomenon.Silk mask uses the softst exquisiteness
Silkworm silk, can be close to skin texture, therefore the highest at the docile degree of deposited face, and matter is thin, transparent, ventilative, and the wing of nose corners of the mouth can take
Note, lock water moisturizing is persistently deeply.And silk mask can accelerate the reparation of skin self, can be closed by the fine and smooth note of silk fiber
Impaired skin is allowed to rapidly be reparation.Heavier can promote the secretion of collagen protein, potent brighten, uvioresistant, antiinflammatory and pock
Ability.
The pink facial film of albumen vitamin of the present invention is reasonable in design, after only needing face cleaning, takes out facial film and spreads on face, make silkworm silk
Face skin is everywhere close to by facial film, waits for percutaneous absorption facial mask liquid quietly, after 15-20min, removes facial film, No clean, is massaged into gently
Absorb.
Detailed description of the invention
Below the specific embodiment of the present invention is described in detail.
Embodiment 1
A kind of pink facial mask liquid of albumen vitamin, including component A, B component and component C, surplus is water；With facial mask liquid gross weight it is
Meter is the most identical.
Described component A is made up of following components by weight percent:
Potassium chloride 0.04%,
Magnesium sulfate 0.01%,
Sodium chloride 0.64%,
Sodium dihydrogen phosphate 0.0125%,
L-glutaminate 0.0584%,
Glucose 0.45%,
Sodium Pyruvate 0.011%,
γ-aminobutyric acid 0.0005%,
Hyaluronate sodium 0.4%,
Glycerol 6%；
Described B component is made up of following components by weight percent:
Oligopeptide-1 albumen 0.0005%,
Vitamin B12 0.001%,
Collagen protein 0.0005%；
Described component C is made up of following components by weight percent:
PE9010(phenoxyethanol/Sensiva SC50) 0.35%.
The production method of the above-mentioned pink facial mask liquid of albumen vitamin, comprises the steps:
(1), component A is dissolved in pure water, stirs so that it is fully dissolve；
(2), 115 DEG C of sterilizings 30 minutes；
(3), when being down to 40 DEG C, the cobalamin in component C, B component and the activated protein of the membrane filtration by 0.22 μm are added, then
Continue to stir；
(4), finally regulation pH value, between 5.5 to 6.0, gets product.Fill, sealing, packaging.
Embodiment 2
A kind of pink facial mask liquid of albumen vitamin, including component A, B component and component C, surplus is water；
Described component A is made up of following components by weight percent:
Potassium chloride 0.02%,
Magnesium sulfate 0.03%,
Sodium chloride 0.6%,
Sodium dihydrogen phosphate 0.01%,
L-glutaminate 0.05%,
Glucose 0.4%,
Sodium Pyruvate 0.012%,
γ-aminobutyric acid 0.0008%,
Hyaluronate sodium 0.2%,
Glycerol 8%；
Described B component is made up of following components by weight percent:
Oligopeptide-1 albumen 0.0008%,
Vitamin B12 0.0005%,
Collagen protein 0.0002%；
Described component C is made up of following components by weight percent:
PE9010(phenoxyethanol/Sensiva SC50) 0.35%.
Preparation method is with embodiment 1.
Embodiment 3
A kind of pink facial mask liquid of albumen vitamin, including component A, B component and component C, surplus is water；
Described component A is made up of following components by weight percent:
Potassium chloride 0.03%,
Magnesium sulfate 0.05%,
Sodium chloride 0.5%,
Sodium dihydrogen phosphate 0.02%,
L-glutaminate 0.07%,
Glucose 0.3%,
Sodium Pyruvate 0.01%,
γ-aminobutyric acid 0.0002%,
Hyaluronate sodium 0.5%,
Glycerol 5%；
Described B component is made up of following components by weight percent:
Oligopeptide-1 albumen 0.0006%,
Vitamin B12 0.005%,
Collagen protein 0.0007%；
Described component C is made up of following components by weight percent:
PE9010(phenoxyethanol/Sensiva SC50) 0.35%.
Preparation method is with embodiment 1.
Embodiment 4
A kind of pink facial mask liquid of albumen vitamin, including component A, B component and component C, surplus is water；
Described component A is made up of following components by weight percent:
Potassium chloride 0.05%,
Magnesium sulfate 0.04%,
Sodium chloride 0.8%,
Sodium dihydrogen phosphate 0.03%,
L-glutaminate 0.06%,
Glucose 0.2%,
Sodium Pyruvate 0.015%,
γ-aminobutyric acid 0.001%,
Hyaluronate sodium 0.3%,
Glycerol 7%；
Described B component is made up of following components by weight percent:
Oligopeptide-1 albumen 0.0002%,
Vitamin B12 0.003%,
Collagen protein 0.001%；
Described component C is made up of following components by weight percent:
PE9010(phenoxyethanol/Sensiva SC50) 0.35%.
Preparation method is with embodiment 1.
Embodiment 5
A kind of pink facial mask liquid of albumen vitamin, including component A, B component and component C, surplus is water；
Described component A is made up of following components by weight percent:
Potassium chloride 0.04%,
Magnesium sulfate 0.02%,
Sodium chloride 0.7%,
Sodium dihydrogen phosphate 0.015%,
L-glutaminate 0.08%,
Glucose 0.5%,
Sodium Pyruvate 0.014%,
γ-aminobutyric acid 0.0006%,
Hyaluronate sodium 0.4%,
Glycerol 6.5%；
Described B component is made up of following components by weight percent:
Oligopeptide-1 albumen 0.001%,
Vitamin B12 0.002%,
Collagen protein 0.0007%；
Described component C is made up of following components by weight percent:
PE9010(phenoxyethanol/Sensiva SC50) 0.35%.
Preparation method is with embodiment 1.
It should be noted last that, above example is only in order to illustrate technical scheme and unrestricted, although ginseng
It is described in detail according to the embodiment of the present invention, it will be understood by those within the art that, to technical scheme
Modifying or equivalent, without departure from the spirit and scope of technical scheme, it all should contain the present invention's
In claims.
Claims (10)
1. the pink facial mask liquid of albumen vitamin, it is characterised in that: include active substance and nutritional labeling, described active substance
For recombined human derived collagen albumen and oligopeptide-1 albumen, described nutritional labeling is vitamin B12.
The pink facial mask liquid of albumen vitamin the most according to claim 1, it is characterised in that: described recombination human source collagen protein
Content be 0.0002 ~ 0.001%；The content of described oligopeptide-1 albumen is 0.0002 ~ 0.001%；The content of described vitamin B12
It is 0.0005 ~ 0.005%.
The pink facial mask liquid of albumen vitamin the most according to claim 1 and 2, it is characterised in that: described active substance and battalion
Form and point be dissolved in balanced salt solution.
The pink facial mask liquid of albumen vitamin the most according to claim 3, it is characterised in that: described balanced salt solution adds
Glycerol, γ-aminobutyric acid, Sodium Pyruvate and hyaluronate sodium.
The pink facial mask liquid of albumen vitamin the most according to claim 4, it is characterised in that: the content of described glycerol is 5 ~
8%, the content of described γ-aminobutyric acid is 0.0002 ~ 0.001%, and the content of described Sodium Pyruvate is 0.01 ~ 0.015%, described
The content of hyaluronate sodium is 0.2 ~ 0.5%.
The pink facial mask liquid of albumen vitamin the most according to claim 5, it is characterised in that: described balanced salt solution includes chlorine
Change potassium, magnesium sulfate, sodium chloride, sodium dihydrogen phosphate, L-glutaminate and glucose sugar, wherein, the content of potassium chloride is 0.02 ~
0.05%, the content of magnesium sulfate is 0.01 ~ 0.05%, and the content of sodium chloride is 0.5 ~ 0.8%, the content of sodium dihydrogen phosphate is 0.01 ~
0.03%, the content of L-glutaminate is 0.05 ~ 0.08%, and the content of glucose is 0.2 ~ 0.5%.
The pink facial mask liquid of albumen vitamin the most according to claim 6, it is characterised in that: include component A, B component and C group
Point, surplus is water；
Described component A is made up of following components by weight percent:
Potassium chloride 0.04%,
Magnesium sulfate 0.01%,
Sodium chloride 0.64%,
Sodium dihydrogen phosphate 0.0125%,
L-glutaminate 0.0584%,
Glucose 0.45%,
Sodium Pyruvate 0.011%,
γ-aminobutyric acid 0.0005%,
Hyaluronate sodium 0.4%,
Glycerol 6%；
Described B component is made up of following components by weight percent:
Oligopeptide-1 albumen 0.0005%,
Vitamin B12 0.001%,
Collagen protein 0.0005%；
Described component C is made up of following components by weight percent:
PE9010 0.35%。
8. the production method of the pink facial mask liquid of albumen vitamin described in a claim 7, it is characterised in that: include walking as follows
Rapid:
(1), component A is dissolved in pure water, stirs so that it is fully dissolve；
(2), 115 DEG C of sterilizings 30 minutes；
(3), when being down to 40 DEG C, the cobalamin in component C, B component and the activated protein of the membrane filtration by 0.22 μm are added, then
Continue to stir；
(4), finally regulation pH value, to 5.5 ~ 6.0, gets product.
9. a facial film, including face paper, it is characterised in that: infiltration facial mask liquid described in claim 1-7 on described face paper.
Facial film the most according to claim 9, it is characterised in that: described face paper is silk mask.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610688008.0A CN106309151A (en) | 2016-08-19 | 2016-08-19 | Protein vitamin pink mask liquid and production method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610688008.0A CN106309151A (en) | 2016-08-19 | 2016-08-19 | Protein vitamin pink mask liquid and production method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106309151A true CN106309151A (en) | 2017-01-11 |
Family
ID=57744728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610688008.0A Pending CN106309151A (en) | 2016-08-19 | 2016-08-19 | Protein vitamin pink mask liquid and production method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106309151A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109846779A (en) * | 2019-03-06 | 2019-06-07 | 上海乐宝日化股份有限公司 | A kind of maintenance makeup remover and preparation method thereof containing vitamin B12 |
| CN111053719A (en) * | 2020-01-06 | 2020-04-24 | 广州品域美妆创新科技有限公司 | Soothing and whitening composition containing vitamin B12 and application thereof |
| CN113456522A (en) * | 2021-05-19 | 2021-10-01 | 太原理工大学 | Hand cream with recombinant human collagen as nutrient component and preparation method thereof |
| CN114886837A (en) * | 2022-04-20 | 2022-08-12 | 陕西时光未来生物科技有限公司 | Eye essence and preparation method thereof |
| CN116350536A (en) * | 2023-03-20 | 2023-06-30 | 上海肌效派生物科技有限公司 | Recombinant humanized collagen composition and application thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1813663A (en) * | 2005-12-02 | 2006-08-09 | 何秋莎 | Skin care product |
| CN103122027A (en) * | 2012-11-26 | 2013-05-29 | 杨霞 | Recombinant human collagen and production method thereof |
-
2016
- 2016-08-19 CN CN201610688008.0A patent/CN106309151A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1813663A (en) * | 2005-12-02 | 2006-08-09 | 何秋莎 | Skin care product |
| CN103122027A (en) * | 2012-11-26 | 2013-05-29 | 杨霞 | Recombinant human collagen and production method thereof |
Non-Patent Citations (4)
| Title |
|---|
| （美）斯莫尔: "《化学换肤、微晶磨削与外用产品实用指南》", 30 September 2015, 北京大学医学出版社 * |
| 山西锦波生物医药股份有限公司: "重源维他命多肽粉红面膜", 《125.35.6.80:8080/FTBA/ITOWNET/HZP_BA/》 * |
| 张跃西: "《养生旅游产品设计》", 31 December 2015, 中国环境科学出版社 * |
| 杨新建: "《动物细胞培养技术》", 31 August 2013, 中国农业大学出版社 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109846779A (en) * | 2019-03-06 | 2019-06-07 | 上海乐宝日化股份有限公司 | A kind of maintenance makeup remover and preparation method thereof containing vitamin B12 |
| CN111053719A (en) * | 2020-01-06 | 2020-04-24 | 广州品域美妆创新科技有限公司 | Soothing and whitening composition containing vitamin B12 and application thereof |
| CN113456522A (en) * | 2021-05-19 | 2021-10-01 | 太原理工大学 | Hand cream with recombinant human collagen as nutrient component and preparation method thereof |
| CN114886837A (en) * | 2022-04-20 | 2022-08-12 | 陕西时光未来生物科技有限公司 | Eye essence and preparation method thereof |
| CN114886837B (en) * | 2022-04-20 | 2024-06-11 | 山东时光未来生物科技有限公司 | Eye essence and preparation method thereof |
| CN116350536A (en) * | 2023-03-20 | 2023-06-30 | 上海肌效派生物科技有限公司 | Recombinant humanized collagen composition and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106309151A (en) | Protein vitamin pink mask liquid and production method | |
| CN105107007B (en) | A kind of medical protective dressing of cation and preparation method thereof | |
| CN106176282B (en) | Protein powder film liquid and production method | |
| CN106902381A (en) | Recombination human source collagen stoste, dressing and their preparation method | |
| CN110882207B (en) | Preparation process and method of essence for skin repair | |
| CN107496309A (en) | Antiallergic Face-protecting mask | |
| CN106137916A (en) | The cosmetic composition of a kind of removing acnes and controlling oil whitening and application thereof | |
| CN103565729B (en) | Condensation and preparation method thereof is repaired in a kind of black Fructus Lycii moisturizing | |
| CN106176556A (en) | A kind of removing acnes and controlling oil whitening cream | |
| CN107714504A (en) | A kind of same human-like collagen composition and its applied in cosmetics | |
| CN106265415A (en) | A kind of have moisturizing and the skin care compositions of after-sun restorative function and application thereof | |
| CN106420482A (en) | Skin energy activating sparkling essence | |
| CN104434642B (en) | A kind of after-sun restorative skin whitening, moisturizing condensation and preparation method thereof | |
| CN111265441A (en) | Composition capable of enhancing skin night repair and regeneration capacity and application thereof | |
| CN105232426A (en) | Beautifying composition capable of tendering skin rapidly and application of beautifying composition | |
| CN104546591A (en) | Plant essential oil facial mask and preparation method thereof | |
| CN107714631A (en) | A kind of collagen peptide facial mask liquid and preparation method thereof | |
| KR102249700B1 (en) | Comsmetic composition comprising mint vinegar | |
| CN109381390A (en) | A kind of sodium hyaluronate skin lightening Face-protecting mask and preparation method thereof | |
| CN111759762A (en) | Black eye removing composition, essence and preparation method thereof | |
| CN112716846A (en) | Jasmine hot spring lip balm with repairing effect | |
| CN104188854A (en) | Nutritional alcohol-free nourishing astringent lotion | |
| CN114159341B (en) | Freeze-dried eye patch and preparation method thereof | |
| CN107137316B (en) | Dendrobium lip balm and preparation method thereof | |
| CN104546598A (en) | Preparation method of facial masks containing plant essential oil |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20170113 Address after: Xiaoshan Jincheng Road Hangzhou city Zhejiang province 311200 No. 385 4 floor Applicant after: Zhejiang Yuan Yuan Biotechnology Co.,Ltd. Address before: 030032 Shanxi city of Taiyuan province by the economic and Technological Development Zone No. 18 North Street Applicant before: SHANXI JINBO BIO-PHARMACEUTICAL Co.,Ltd. |
|
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20181025 Address after: 030032 Taiyuan economic and Technological Development Zone, Shanxi, 18 North Street. Applicant after: SHANXI JINBO BIO-PHARMACEUTICAL Co.,Ltd. Address before: 311200 4, Jincheng Road, Xiaoshan District, Hangzhou, Zhejiang, 4 Applicant before: Zhejiang Yuan Yuan Biotechnology Co.,Ltd. |
|
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170111 |